
    
      OBJECTIVES:

        -  Determine the effects of EGFR inhibitors on magnesium homeostasis in patients with
           cancer.

      OUTLINE: This is a pilot study.

      Patients undergo blood and urine sample collection at baseline and at 2, 4, and 8 weeks
      during treatment.

      After finishing treatment, patients are followed periodically for up to 10 weeks.
    
  